Cardiorentis AG

Industry

  • Miscellaneous
  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
See more in Biomedtracker

Latest on Cardiorentis AG

Scrip

Pipeline Watch: Phase III Progress With Erenumab, Sirukumab And Sarilumab

 
• By John Davis

The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between November 11 and November 17, 2016,

In Vivo

Execs On The Move, February 2016

 
• By Regina Paleski

New At The Helm Company Changes ALLEN , Lee F., MD, PhD To: Argos Therapeutics Inc. , CMO (January) From: Spectrum Pharmaceuticals Inc., CMO Phone: 919-287-6300 ANSARI , Nick To: EnteroMedi

Scrip

Start-Up Execs On The Move, February 2016

 
• By Regina Paleski

Start-Up Execs Abide Therapeutics Inc. Chan Beals, MD, PhD To: CMO (January) From: Entrepreneur in Residence, Merck Research Laboratories Ventures Phone: 858-427-2590 Annexon Biosciences Inc.

Scrip

Venture Funding Deals, February 2016

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Steven Muntner, and Maureen Riordan

IN VITRO DIAGNOSTICS bioTheranostics Inc. Late round brings $32mm to bioTheranostics ; company becomes independent Molecular diagnostics firm bioTheranostics Inc. raised $32mm in a late-stage f